# Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI

> **NCT05951400** · PHASE2,PHASE3 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 200 (actual)

## Conditions studied

- IVF
- PCO

## Interventions

- **DRUG:** Dydrogesterone Tablets
- **DRUG:** Cetrorelix

## Key facts

- **NCT ID:** NCT05951400
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951400, "Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05951400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*